Abstract
Aim:Talimogene laherparepvec (T-VEC) is a genetically modified oncolytic herpesvirus approved for the treatment of unresectable, locoregionally advanc......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
